Overview

Hydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT)

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate whether a physiologically low hydrocortisone (HC) dose is better for cognition as compared to a physiologically high HC dose. In addition, quality of life, metabolic profile and somatosensation will be described in relation to HC dose.
Phase:
Phase 4
Details
Lead Sponsor:
University Medical Center Groningen
Treatments:
Cortisol succinate
Epinephrine
Epinephryl borate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Racepinephrine